Publicacións en colaboración con investigadores/as de Oslo University Hospital (7)

2023

  1. Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

    Haematologica

2019

  1. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    The Lancet, Vol. 394, Núm. 10214, pp. 2096-2107

  2. Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 20, Núm. 6, pp. 781-794

2014

  1. A new non-expressed allele HLA-A*03:168N, identified by serological and sequence-based typing in a voluntary Norwegian hematopoietic stem cell donor

    Tissue Antigens, Vol. 83, Núm. 3, pp. 195-196

2012

  1. Continuous infusion in haemophilia: Current practice in Europe

    Haemophilia, Vol. 18, Núm. 5, pp. 753-759

2010

  1. Non-genetic risk factors and the development of inhibitors in haemophilia: A comprehensive review and consensus report

    Haemophilia, Vol. 16, Núm. 5, pp. 747-766

2002

  1. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

    Blood, Vol. 100, Núm. 12, pp. 3877-3886